Paper23616629
CT-pathologic correlation in primary hepatocellular carcinoma: an implication for target delineation.
Chen HY and 5 others. J Radiat Res, 2013. Cited by 4 papers, by iCite.
Cite this record
ConductScience Library. CT-pathologic correlation in primary hepatocellular carcinoma: an implication for target delineation. Papers, record 23616629. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/23616629
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- CT-pathologic correlation in primary hepatocellular carcinoma: an implication for target delineation.
- PubMed
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Carcinoma, Hepatocellular | Major topic |
| Liver Neoplasms | Major topic |
| Tomography, X-Ray Computed | Major topic |
| Adult | |
| Aged | |
| China | |
| Female | |
| Humans | |
| Male | |
| Middle Aged | |
| Neoplasm Invasiveness | |
| Prevalence | |
| Reproducibility of Results | |
| Sensitivity and Specificity | |
| Statistics as Topic | |
| Tumor Burden |
Source PubMed
References18
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 1352268 | Natural history of small untreated hepatocellular carcinoma in cirrhosis: a multivariate analysis of prognostic factors of tumor growth rate and patient survival. | Hepatology | 1992 | https://conductscience.org/library/papers/1352268 | PubMed |
| 2 | 16314634 | Phase II trial of high-dose conformal radiation therapy with concurrent hepatic artery floxuridine for unresectable intrahepatic malignancies. | J Clin Oncol | 2005 | https://conductscience.org/library/papers/16314634 | PubMed |
| 3 | 20031332 | Approach to radiation therapy in hepatocellular carcinoma. | Cancer Treat Rev | 2010 | https://conductscience.org/library/papers/20031332 | PubMed |
| 4 | 20731853 | Prospective evaluation of microscopic extension using whole-mount preparation in patients with hepatocellular carcinoma: Definition of clinical target volume for radiotherapy. | Radiat Oncol | 2010 | https://conductscience.org/library/papers/20731853 | PubMed |
| 5 | 23070690 | Recent progress in understanding, diagnosing, and treating hepatocellular carcinoma. | CA Cancer J Clin | 2012 | https://conductscience.org/library/papers/23070690 | PubMed |
| 6 | 20231127 | Phase I feasibility trial of stereotactic body radiation therapy for primary hepatocellular carcinoma. | Clin Transl Oncol | 2010 | https://conductscience.org/library/papers/20231127 | PubMed |
| 7 | 16982547 | Stereotactic body radiation therapy for primary and metastatic liver tumors: A single institution phase i-ii study. | Acta Oncol | 2006 | https://conductscience.org/library/papers/16982547 | PubMed |
| 8 | 15530260 | A comparison of chemoembolization combination with and without radiotherapy for unresectable hepatocellular carcinoma. | Cancer J | 2004 | https://conductscience.org/library/papers/15530260 | PubMed |
| 9 | 18172187 | Phase I study of individualized stereotactic body radiotherapy for hepatocellular carcinoma and intrahepatic cholangiocarcinoma. | J Clin Oncol | 2008 | https://conductscience.org/library/papers/18172187 | PubMed |
| 10 | 11668491 | Estimating the world cancer burden: Globocan 2000. | Int J Cancer | 2001 | https://conductscience.org/library/papers/11668491 | PubMed |
| 11 | 21939856 | Radiation therapy for hepatocellular carcinoma. | Semin Radiat Oncol | 2011 | https://conductscience.org/library/papers/21939856 | PubMed |
| 12 | 19406586 | Impact factors for microinvasion in patients with hepatocellular carcinoma: possible application to the definition of clinical tumor volume. | Int J Radiat Oncol Biol Phys | 2010 | https://conductscience.org/library/papers/19406586 | PubMed |
| 13 | 21939853 | Imaging and image-guided radiation therapy in liver cancer. | Semin Radiat Oncol | 2011 | https://conductscience.org/library/papers/21939853 | PubMed |
| 14 | 18391616 | Hepatocellular carcinoma: radiation therapy. | Cancer J | 2008 | https://conductscience.org/library/papers/18391616 | PubMed |
| 15 | 21939852 | Overview: Where does radiation therapy fit in the spectrum of liver cancer local-regional therapies? | Semin Radiat Oncol | 2011 | https://conductscience.org/library/papers/21939852 | PubMed |
| 16 | 12182985 | Dose-response relationship in local radiotherapy for hepatocellular carcinoma. | Int J Radiat Oncol Biol Phys | 2002 | https://conductscience.org/library/papers/12182985 | PubMed |
| 17 | 17145534 | Feasibility and efficacy of high-dose three-dimensional-conformal radiotherapy in cirrhotic patients with small-size hepatocellular carcinoma non-eligible for curative therapies--mature results of the French Phase II RTF-1 trial. | Int J Radiat Oncol Biol Phys | 2006 | https://conductscience.org/library/papers/17145534 | PubMed |
| 18 | 16317267 | Retrospective clinicopathologic correlation of gross tumor size of hepatocellular carcinoma: implications for stereotactic body radiotherapy. | Am J Clin Oncol | 2005 | https://conductscience.org/library/papers/16317267 | PubMed |
Cited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 38720338 | Microinvasion in hepatocellular carcinoma: predictive factor and application for definition of clinical target volume for radiotherapy. | World J Surg Oncol | 2024 | https://conductscience.org/library/papers/38720338 | PubMed |
| 36097772 | Influence of different region of interest sizes on CT-based radiomics model for microvascular invasion prediction in hepatocellular carcinoma. | Zhong Nan Da Xue Xue Bao Yi Xue Ban | 2022 | https://conductscience.org/library/papers/36097772 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| AFP | 174 | PubTator's text mining | https://conductscience.org/library/genes/174 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/23616629
GET https://conductscience.org/api/papers/v1/23616629/authors